Phase II Feasibility Study of FOLFIRINOX-Losartan Followed by Accelerated Short Course Radiation Therapy With Proton Beam for Locally Advanced Pancreatic Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Losartan (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Pancreatic cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 25 Sep 2020 Biomarkers information updated
- 19 Jul 2013 Planned End Date changed from 1 May 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.
- 01 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.